Lasik Surgery Market By Technology (Wavefront-Guided LASIK, Wavefront-Optimized LASIK, Topography Assisted LASIK, All Laser), By End user (Hospitals, Eye Clinics, Ambulatory Surgical Centers), and Geography     

LASIK Surgery Market size was valued at USD 3.4 billion in 2021 and is expected to reach a value of USD 5.5 billion by 2028, growing at a CAGR of 7.1% during 2022-28. The Lasik or laser-assisted in-situ keratomileusis is the most commonly performed laser refractive eye surgery to treat myopia (nearsightedness), astigmatism and hyperopia (farsightedness). This LASIK procedure is done for reshaping the cornea and enable light entering the eye to be properly focused on the retina for a clear vision. In a majority of the cases LASIK surgery is a painless procedure and completed within 15 minutes for both eyes and recovery period is as little as 24 hours. The LASIK procedure helps the sighted people free from the lenses, however in it may not completely restore the sight, and may request to use corrective lenses to perform some critical tasks. Global LASIK surgery market is composed of many market players and a majority of the market is dominated by some strong players. Companies in LASIK surgery market is engaged in mergers, acquisitions and collaborations to increase their product portfolio in the market and strengthen their market position. For instance, In September 2016, Johnson & Johnson Inc. entered into definitive agreement to acquire Abbot Medical Optics of Abbot Laboratories to strengthen their product portfolio in ophthalmic products. This acquisition includes Abbot Medical Ophthalmics advanced laser vision technology designed to surgeon productivity and corrects the sightedness and astigmatism. Furthermore, companies also focusing on the new product developments, advancing the existing technologies to diversify their products and grab the market share. Key Developments: In November 2015, Alcon, a subsidiary of Novartis AG has introduced “countoura vision”, as first personalised LASIK procedure In December 2013, U.S. Food and Drug Administration approved Nidek, Inc.’s topography assisted LASIK system, “Nidek EC – 5000 Excimer Laser System”